NYSE:BDXMedical Equipment
Becton Dickinson FDA Win Adds Breast Biopsy Growth And Valuation Interest
Becton Dickinson (NYSE:BDX) received FDA clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System.
The clearance adds a new multi modality breast biopsy platform to BD's breast health portfolio.
The system is designed to support diagnostic procedures for earlier detection and assessment of breast disease.
For you as an investor, this FDA decision sits at the core of what Becton Dickinson does. The company focuses on medical devices and diagnostic solutions, and breast...